PortfoliosLab logoPortfoliosLab logo
SBIO vs. AMLP
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SBIO vs. AMLP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ALPS Medical Breakthroughs ETF (SBIO) and Alerian MLP ETF (AMLP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBIO achieves a 1.95% return, which is significantly lower than AMLP's 17.77% return. Over the past 10 years, SBIO has outperformed AMLP with an annualized return of 8.03%, while AMLP has yielded a comparatively lower 6.74% annualized return.


SBIO

1D
2.35%
1M
-5.55%
YTD
1.95%
6M
4.13%
1Y
68.86%
3Y*
18.38%
5Y*
3.16%
10Y*
8.03%

AMLP

1D
1.25%
1M
0.71%
YTD
17.77%
6M
15.18%
1Y
20.38%
3Y*
20.70%
5Y*
17.19%
10Y*
6.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBIO vs. AMLP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SBIO
ALPS Medical Breakthroughs ETF
1.95%55.07%3.81%8.68%-28.08%-17.55%21.17%50.30%-11.81%45.67%
AMLP
Alerian MLP ETF
17.77%5.78%22.76%21.40%25.47%39.09%-32.26%5.99%-12.67%-7.89%

Correlation

The correlation between SBIO and AMLP is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2015

0.28

The correlation between SBIO and AMLP shifts across timeframes, from -0.03 (1 year) to 0.29 (10 years), reflecting how their relationship changes across market environments.

SBIO vs. AMLP - Sectors Allocation Comparison


Sectors
SBIO
AMLP

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

97.7%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

2.3%

Financial Services

-0.0%

-

Healthcare

SBIO
100.0%
AMLP

-

Basic Materials

SBIO

-

AMLP

-

Communication Services

SBIO

-

AMLP

-

Consumer Cyclical

SBIO

-

AMLP

-

Consumer Defensive

SBIO

-

AMLP

-

Energy

SBIO

-

AMLP
97.7%

Industrials

SBIO

-

AMLP

-

Real Estate

SBIO

-

AMLP

-

Technology

SBIO

-

AMLP

-

Utilities

SBIO

-

AMLP
2.3%

Financial Services

SBIO
-0.0%
AMLP

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBIO vs. AMLP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBIO
SBIO Risk / Return Rank: 7676
Overall Rank
SBIO Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
SBIO Sortino Ratio Rank: 7272
Sortino Ratio Rank
SBIO Omega Ratio Rank: 6363
Omega Ratio Rank
SBIO Calmar Ratio Rank: 9090
Calmar Ratio Rank
SBIO Martin Ratio Rank: 8282
Martin Ratio Rank

AMLP
AMLP Risk / Return Rank: 4949
Overall Rank
AMLP Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
AMLP Sortino Ratio Rank: 5050
Sortino Ratio Rank
AMLP Omega Ratio Rank: 4949
Omega Ratio Rank
AMLP Calmar Ratio Rank: 4747
Calmar Ratio Rank
AMLP Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBIO vs. AMLP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Alerian MLP ETF (AMLP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SBIOAMLPDifference
Sharpe ratioReturn per unit of total volatility

+0.61

Sortino ratioReturn per unit of downside risk

+0.80

Omega ratioGain probability vs. loss probability

1.38

1.30

+0.07

Calmar ratioReturn relative to maximum drawdown

5.47

2.29

+3.18

Martin ratioReturn relative to average drawdown

16.23

7.60

+8.63

SBIO vs. AMLP - Sharpe Ratio Comparison

The current SBIO Sharpe Ratio is 2.35, which is higher than the AMLP Sharpe Ratio of 1.74. The chart below compares the historical Sharpe Ratios of SBIO and AMLP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SBIOAMLPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.35

1.74

+0.61

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.09

0.86

-0.77

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.24

0.24

0.00

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.23

-0.01

Drawdowns

SBIO vs. AMLP - Drawdown Comparison

The maximum SBIO drawdown since its inception was -63.06%, smaller than the maximum AMLP drawdown of -77.19%. Use the drawdown chart below to compare losses from any high point for SBIO and AMLP.


Loading charts...

Drawdown Indicators


SBIOAMLPDifference

Max Drawdown

Largest peak-to-trough decline

-63.06%

-77.19%

+14.13%

Max Drawdown (1Y)

Largest decline over 1 year

-12.66%

-8.94%

-3.72%

Max Drawdown (3Y)

Largest decline over 3 years

-42.44%

-14.27%

-28.17%

Max Drawdown (5Y)

Largest decline over 5 years

-53.10%

-20.92%

-32.18%

Max Drawdown (10Y)

Largest decline over 10 years

-63.06%

-72.62%

+9.56%

Current Drawdown

Current decline from peak

-14.84%

-2.90%

-11.94%

Average Drawdown

Average peak-to-trough decline

-28.44%

-17.40%

-11.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.26%

2.69%

+1.57%

Volatility

SBIO vs. AMLP - Volatility Comparison

ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 9.85% compared to Alerian MLP ETF (AMLP) at 5.08%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than AMLP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SBIOAMLPDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.85%

5.08%

+4.77%

Volatility (6M)

Calculated over the trailing 6-month period

22.76%

8.65%

+14.11%

Volatility (1Y)

Calculated over the trailing 1-year period

29.40%

11.88%

+17.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.57%

19.99%

+13.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.18%

27.67%

+5.51%

SBIO vs. AMLP - Expense Ratio Comparison

SBIO has a 0.50% expense ratio, which is lower than AMLP's 0.90% expense ratio.


Dividends

SBIO vs. AMLP - Dividend Comparison

SBIO has not paid dividends to shareholders, while AMLP's dividend yield for the trailing twelve months is around 7.55%.


PositionTTM20252024202320222021202020192018201720162015
AMLP
Alerian MLP ETF
7.55%8.36%7.70%7.86%7.70%8.55%12.31%9.12%9.29%7.97%8.09%9.84%
SBIO
ALPS Medical Breakthroughs ETF
0.00%0.00%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%0.00%0.00%

Frequently Asked Questions


SBIO and AMLP have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SBIO has higher volatility (9.85%) compared to AMLP (5.08%). In terms of maximum drawdown, SBIO dropped -63.06% vs AMLP's -77.19%.

On 10-year performance, SBIO leads with 8.03% vs 6.74% for AMLP. On fees, SBIO is cheaper at 0.50% per year. On volatility, AMLP has been the lower-risk option at 5.08%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SBIO has performed better with a 8.03% return vs 6.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SBIO is cheaper with a 0.50% expense ratio, compared with 0.90% for AMLP.

AMLP has the higher dividend yield at 7.55%, compared with 0.00% for SBIO.

SBIO is categorized as Health & Biotech Equities, while AMLP is MLPs. SBIO tracks S-Network Medical Breakthroughs Index, while AMLP tracks Alerian MLP Infrastructure Index. Their fees differ too: 0.50% for SBIO and 0.90% for AMLP.

SBIO currently has the higher Sharpe Ratio (2.35 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SBIO and AMLP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer